Nektar Therapeutics (NKTR) vs STAAR Surgical Company (STAA)

A side-by-side comparison of Nektar Therapeutics and STAAR Surgical Company across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — NKTR vs STAA

growth of $100 · dividends reinvested · last 10y
NKTR -82.3% (-15.9%/yr)STAA +145.3% (+9.4%/yr)STAA compounded faster over this window
Log scale — wide-divergence pair
1101001k10kStart $10020182020202220242026$18$245
NKTR STAA

NKTR vs STAA: by the numbers

  • •NKTR is the larger company ($1.14B vs $1.10B market cap).
  • •STAA is profitable (1.13% net margin) while NKTR runs a net loss (-287.84%).
  • •STAA grew revenue faster over the past five years (10.49% vs -12.34% CAGR).

Metrics side by side

Valuation

MetricNKTRSTAA
P/E ratioN/A276.87
Forward P/EN/A76.31
P/S ratio20.973.25
P/B ratio1.273.02
EV / EBITDAN/A22.47

Profitability

MetricNKTRSTAA
Gross margin99.36%76.23%
Operating margin-240.38%-19.19%
Net margin-287.84%1.13%
ROE-17.40%1.05%
ROIC-12.53%4.80%

Growth (annualized)

MetricNKTRSTAA
Revenue CAGR (5Y)-12.34%10.49%
Total return CAGR (5Y)-30.33%-28.41%

Frequently asked

Which has grown faster, NKTR or STAA?
Over the past five years, STAA grew revenue faster — NKTR at a -12.34% CAGR versus STAA at 10.49%.
Is NKTR or STAA more profitable?
STAA runs the higher net margin — NKTR at -287.84% versus STAA at 1.13%.
How have NKTR and STAA total returns compared?
Over the past 10 years, NKTR delivered -16.49% and STAA delivered 9.25% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.